December 5, 2006
Take Heart: Study Validates Folic Acid Decreases Risk of Heart Disease and Stroke, Reinforces Animi-3 Formula
GORDONSVILLE, VA—A new study in British Medical Journal* reviews the scientific evidence published in previous studies that supports the use of folic acid as a way of reducing the risk of heart disease and strokes. Lead author and heart expert Dr. David Wald and colleagues clarify existing debate over the relationship between elevated homocysteine levels, a risk factor for heart disease, and folic acid supplementation:
“Since folic acid reduces homocysteine concentrations, to an extent dependent on background folate levels, it follows that increasing folic acid consumption will reduce the risk of heart attack and stroke by an amount related to the homocysteine reduction achieved. We therefore take the view that the evidence is now sufficient to justify action on lowering homocysteine concentrations.”
Studies published in peer-reviewed journals have reported that patients with cardiovascular disease, diabetes, rheumatoid arthritis, and depression may be deficient in vital nutrients:
- DHA (Omega-3)
- Folic acid
- Vitamin B6 and B12
Addressing these deficiencies may reduce cardiovascular risk.**
“Dr. Wald provides an encompassing review of studies and randomized trials that seem to show that folic acid consumption has a protective effect against heart disease. A cardiovascular risk reduction effect has also been previously attributed to omega-3 fatty acid consumption from marine sources, such as the omega-3 in Animi-3.”
Animi-3 is a prescription product that contains highly refined DHA (omega-3), folic acid, vitamins B6 and B12. Animi-3 is indicated for improving nutritional status in conditions requiring DHA, (omega-3), folic acid, Vitamin B12, or B6 supplementation. Animi-3 is not intended to diagnose, treat, or cure any disease.
**FDA “Qualified Health Claims” B vitamins & Vascular Disease. As part of a well-balanced diet that is low in saturated fat and cholesterol, Folic Acid, Vitamin B6 and Vitamin B12 may reduce the risk of vascular disease. FDA evaluated the above claim and found that, while it is known that diets low in saturated fat and cholesterol reduce the risk of heart disease and other vascular diseases, the evidence in support of the above claim is inconclusive. Docket No. 99P-3029.